Clotrimazole/Diclofenac Sodium

克霉唑/双氯芬酸钠

Report date: 2022/07/04 19:38:02

Base Information

Drug NameClotrimazole/Diclofenac Sodium
Drug Alias Name双氯芬酸钠/克霉唑Diclofenac Sodium/ClotrimazoleDiclofenac/ClotrimazoleClotrimazole/DiclofenacCandiplus +[6] 
ClassificationSmall molecules
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsCyclooxygenases inhibitors
TargetsCyclooxygenasesLanosterol 14α-demethylase
Therapy Area/IndicationsCandidiasis, VulvovaginalCandidiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySlovakiaPolandAustria
CombinationsYes ClotrimazoleDiclofenac Sodium
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesProfem Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesProfem Gmbh
Inactive CompaniesN/A
Active IndicationsCandidiasis, Vulvovaginal
Inactive IndicationsCandidiasis

Other Information

ATC CodeN/A
Related LinksN/A